Last updated: September 28, 2022
Sponsor: Eskisehir Osmangazi University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pregnancy Complications
Treatment
N/AClinical Study ID
NCT05558969
ESOGU 4
Ages 18-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Pregnant women who are scheduled for cesarean section under general anesthesia (pregnant women who do not use magnesium) and who use magnesium for prophylaxis inpreeclampsia.
Exclusion
Exclusion Criteria:
- Eclampsia,
- chronic hypertension,
- connective tissue disorder,
- muscle disease, neurological problems,
- thyroid dysfunction,
- kidney disease, heart disease,
- patients with severe allergic reaction to the agents to be used,
- sepsis,
- hypovolemia, abruptio placenta, placenta previa,
- conditions that will prolong the effect of muscle relaxants (drug use ),
- pregnant women who did not want to be included in the study
Study Design
Total Participants: 30
Study Start date:
September 28, 2022
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Eskisehir Osmangazi Universıty Faculty of Medicine
Eskisehir,
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.